Page last updated: 2024-09-05

lu 135252 and Albuminuria

lu 135252 has been researched along with Albuminuria in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dieterich, M; Kossmehl, P; Kreutz, R; Rothermund, L; Traupe, T; Yagil, C; Yagil, Y1
Amann, K; Gross, ML; Helmke, B; Münter, K; Parkman, A; Ritz, E; Schoof, A; Tulp, O1
Amann, K; El-Shakmak, A; Gross, ML; Hansen, A; Heiss, N; Münter, K; Ritz, E; Szabo, A; Weckbach, M1
Hocher, B; Lun, A; Neumayer, HH; Priem, F; Raschack, M1

Other Studies

4 other study(ies) available for lu 135252 and Albuminuria

ArticleYear
Nephroprotective effects of the endothelin ET(A) receptor antagonist darusentan in salt-sensitive genetic hypertension.
    European journal of pharmacology, 2003, May-16, Volume: 468, Issue:3

    Topics: Albuminuria; Animals; Body Weight; Desoxycorticosterone; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin-1; Hypertension; Kidney; Kidney Diseases; Male; Organ Size; Osteopontin; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred Strains; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger; Sialoglycoproteins; Sodium; Sodium Chloride, Dietary

2003
Renal damage in the SHR/N-cp type 2 diabetes model: comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blocker.
    Laboratory investigation; a journal of technical methods and pathology, 2003, Volume: 83, Issue:9

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Immunohistochemistry; Indoles; Kidney; Male; Phenylpropionates; Proliferating Cell Nuclear Antigen; Pyrimidines; Rats; RNA, Messenger; Transforming Growth Factor beta

2003
ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetes.
    Diabetologia, 2004, Volume: 47, Issue:2

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arterioles; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular Diseases; Collagen Type IV; Coronary Vessels; Diabetes Mellitus, Experimental; Endothelin A Receptor Antagonists; Endothelin-1; Fibrosis; Gene Expression; Heart; Immunohistochemistry; In Situ Hybridization; Indoles; Male; Myocardium; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Transforming Growth Factor beta

2004
Renal endothelin system in diabetes: comparison of angiotensin-converting enzyme inhibition and endothelin-A antagonism.
    Journal of cardiovascular pharmacology, 1998, Volume: 31 Suppl 1

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Kidney; Kidney Function Tests; Mice; Phenylpropionates; Proteinuria; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A

1998